Nitric oxide (NO) has critical roles in a wide variety of key biologic functions and has intricate transport mechanisms for delivery to key distal tissues under normal conditions. However, NO also plays important roles during disease processes, such as hypoxia–ischemia, asphyxia, neuro-inflammation, and retinopathy of prematurity. The effects of exogenous NO on the developing neonatal brain remain controversial. Inhaled NO (iNO) can be neuroprotective or toxic depending on a variety of factors, including cellular redox state, underlying disease processes, duration of treatment, and dose. This review identifies key gaps in knowledge that should prompt further investigation into the possible role of iNO as a therapeutic agent after injury to the brain.
NO is a key signal mediator in the neonatal brain with neuroprotective and neurotoxic properties.
iNO, a commonly used medication, has significant effects on the neonatal brain.
Dosing, duration, and timing of administration of iNO can affect the developing brain.
This review article summarizes the roles of NO in association with various disease processes that impact neonates, such as brain hypoxia–ischemia, asphyxia, retinopathy of prematurity, and neuroinflammation.
The impact of this review is that it clearly describes gaps in knowledge, and makes the case for further, targeted studies in each of the identified areas.
Subscribe to Journal
Get full journal access for 1 year
only $30.69 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Jia, L., Bonaventura, C., Bonaventura, J. & Stamler, J. S. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380, 221–226 (1996).
Hardingham, N., Dachtler, J. & Fox, K. The role of nitric oxide in pre-synaptic plasticity and homeostasis. Front. Cell Neurosci. 7, 190 (2013).
Hopper, R. A. & Garthwaite, J. Tonic and phasic nitric oxide signals in hippocampal long-term potentiation. J. Neurosci. 26, 11513–11521 (2006).
Garthwaite, J. NO as a multimodal transmitter in the brain: discovery and current status. Br. J. Pharm. 176, 197–211 (2019).
Malinski, T., Bailey, F., Zhang, Z. G. & Chopp, M. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 13, 355–358 (1993).
Sato, S., Tominaga, T., Ohnishi, T. & Ohnishi, S. T. EPR spin-trapping study of nitric oxide formation during bilateral carotid occlusion in the rat. Biochim. Biophys. Acta 1181, 195–197 (1993).
Tominaga, T., Sato, S., Ohnishi, T. & Ohnishi, S. T. Potentiation of nitric oxide formation following bilateral carotid occlusion and focal cerebral ischemia in the rat: in vivo detection of the nitric oxide radical by electron paramagnetic resonance spin trapping. Brain Res. 614, 342–346 (1993).
Sato, S., Tominaga, T., Ohnishi, T. & Ohnishi, S. T. Electron paramagnetic resonance study on nitric oxide production during brain focal ischemia and reperfusion in the rat. Brain Res. 647, 91–96 (1994).
Kumura, E. et al. Nitrosyl hemoglobin production during reperfusion after focal cerebral ischemia in rats. Neurosci. Lett. 177, 165–167 (1994).
Zhang, Z. G. et al. Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Res. 654, 85–95 (1994).
Guo, Y. et al. Regulation of cerebellar nitric oxide production in response to prolonged in vivo hypoxia. J. Neurosci. Res. 49, 89–97 (1997).
Groenendaal, F. et al. Cytosolic and membrane-bound cerebral nitric oxide synthase activity during hypoxia in cortical tissue of newborn piglets. Neurosci. Lett. 206, 121–124 (1996).
Jiang, K. et al. Effect of hypoxia and reoxygenation on regional activity of nitric oxide synthase in brain of newborn piglets. Neurosci. Lett. 206, 199–203 (1996).
Grandati, M. et al. Calcium-independent NO-synthase activity and nitrites/nitrates production in transient focal cerebral ischaemia in mice. Br. J. Pharm. 122, 625–630 (1997).
Rushworth, S. A., Bravery, C. A. & Thompson, S. High sequence homology between human and pig CD40 with conserved binding to human CD154. Transplantation 69, 936–940 (2000).
Gonzalez-Ramon, N. et al. The major acute phase serum protein in pigs is homologous to human plasma kallikrein sensitive PK-120. FEBS Lett. 371, 227–230 (1995).
Munson, D. A. et al. Pulmonary and systemic nitric oxide metabolites in a baboon model of neonatal chronic lung disease. Am. J. Respir. Cell. Mol. Biol. 33, 582–588 (2005).
Kuppusamy, P. et al. Three-dimensional imaging of nitric oxide production in the rat brain subjected to ischemia–hypoxia. J. Cereb. Blood Flow Metab. 15, 899–903 (1995).
Kader, A., Frazzini, V. I., Solomon, R. A. & Trifiletti, R. R. Nitric oxide production during focal cerebral ischemia in rats. Stroke 24, 1709–1716 (1993).
Chakravortty, D. & Hensel, M. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect. 5, 621–627 (2003).
Kleinert, H., Schwarz, P. M. & Forstermann, U. Regulation of the expression of inducible nitric oxide synthase. Biol. Chem. 384, 1343–1364 (2003).
MacMicking, J., Xie, Q. W. & Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323–350 (1997).
Nomura, Y. & Kitamura, Y. Inducible nitric oxide synthase in glial cells. Neurosci. Res. 18, 103–107 (1993).
Vannucchi, M. G. et al. Expression of neuronal and inducible nitric oxide synthase in neuronal and glial cells after transient occlusion of the middle cerebral artery. Neuroscience 136, 1015–1026 (2005).
Fernhoff, N. B., Derbyshire, E. R. & Marletta, M. A. A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase. Proc. Natl Acad. Sci. USA 106, 21602–21607 (2009).
Burney, S. et al. The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat. Res. 424, 37–49 (1999).
Moncada, S. & Erusalimsky, J. D. Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell. Biol. 3, 214–220 (2002).
Brown, G. C. & Borutaite, V. Nitric oxide, cytochrome c and mitochondria. Biochem. Soc. Symp. 66, 17–25 (1999).
Manner, C. K., Nicholson, B. & MacLeod, C. L. CAT2 arginine transporter deficiency significantly reduces iNOS-mediated NO production in astrocytes. J. Neurochem. 85, 476–482 (2003).
Kawahara Kea Co-induction of argininosuccinate synthetase, cationic amino acid transporter-2, and nitric oxide synthase in activated murine microglial cells. Brain Res. Mol. Brain Res. 90, 165–173 (2001).
Youn, H. et al. Under-expression of Kalirin-7 Increases iNOS activity in cultured cells and correlates to elevated iNOS activity in Alzheimer’s disease hippocampus. J. Alzheimers Dis. 12, 271–281 (2007).
Cho, H. J. et al. Inducible nitric oxide synthase: identification of amino acid residues essential for dimerization and binding of tetrahydrobiopterin. Proc. Natl Acad. Sci. USA 92, 11514–11518 (1995).
Alderton, W. K., Cooper, C. E. & Knowles, R. G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357, 593–615 (2001).
Clapham, D. E. Calcium signaling. Cell 131, 1047–1058 (2007).
Fischmann, T. Oea Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat. Struct. Biol. 6, 233–242 (1999).
Ratovitski EAea Kalirin inhibition of inducible nitric-oxide synthase. J. Biol. Chem. 274, 993–999 (1999).
Garvey EPea Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J. Biol. Chem. 269, 26669–26676 (1994).
Cinelli, M. A., Do, H. T., Miley, G. P. & Silverman, R. B. Inducible nitric oxide synthase: regulation, structure, and inhibition. Med. Res. Rev. 40, 158–189 (2020).
Tsuji, M. et al. Protective effect of aminoguanidine on hypoxic–ischemic brain damage and temporal profile of brain nitric oxide in neonatal rat. Pediatr. Res. 47, 79–83 (2000).
Zhu, C. et al. Nitrosylation precedes caspase-3 activation and translocation of apoptosis-inducing factor in neonatal rat cerebral hypoxia–ischaemia. J. Neurochem. 90, 462–471 (2004).
Assreuy, J., Cunha, F. Q., Liew, F. Y. & Moncada, S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br. J. Pharm. 108, 833–837 (1993).
Smith, B. C., Fernhoff, N. B. & Marletta, M. A. Mechanism and kinetics of inducible nitric oxide synthase auto-S-nitrosation and inactivation. Biochemistry 51, 1028–1040 (2012).
Christopherson, K. S., Hillier, B. J., Lim, W. A. & Bredt, D. S. PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J. Biol. Chem. 274, 27467–27473 (1999).
Aarts, Mea Treatment of ischemic brain damage by perturbing NMDA receptor–PSD-95 protein interactions. Science 298, 846–850 (2002).
Giesen, J. et al. AMPA induces NO-dependent cGMP signals in hippocampal and cortical neurons via L-type voltage-gated calcium channels. Cereb. Cortex 30, 2128–2143 (2020).
Dawson, V. L. & Dawson, T. M. Deadly conversations: nuclear-mitochondrial cross-talk. J. Bioenerg. Biomembr. 36, 287–294 (2004).
Ischiropoulos, H. & Beckman, J. S. Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J. Clin. Invest. 111, 163–169 (2003).
Eliasson, M. Jea Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3, 1089–1095 (1997).
Berger, N. A. & Berger, S. J. Metabolic consequences of DNA damage: the role of poly (ADP-ribose) polymerase as mediator of the suicide response. Basic Life Sci. 38, 357–363 (1986).
Loeffler Mea Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J. 15, 758–767 (2001).
Pansiot, J. et al. Neuroprotective effect of inhaled nitric oxide on excitotoxic-induced brain damage in neonatal rat. PLoS ONE 5, e10916 (2010).
Lonze, B. E. & Ginty, D. D. Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605–623 (2002).
Lee, H. T. et al. cAMP response element-binding protein activation in ligation preconditioning in neonatal brain. Ann. Neurol. 56, 611–623 (2004).
Rybnikova, E. et al. Preconditioning induces prolonged expression of transcription factors pCREB and NF-kappa B in the neocortex of rats before and following severe hypobaric hypoxia. J. Neurochem. 106, 1450–1458 (2008).
Ping, P. et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ. Res. 84, 587–604 (1999).
Gonzalez-Zulueta, M. et al. Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc. Natl Acad. Sci. USA 97, 436–441 (2000).
Lipton, S. A. et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626–632 (1993).
Lander, H. M., Jacovina, A. T., Davis, R. J. & Tauras, J. M. Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J. Biol. Chem. 271, 19705–19709 (1996).
Mannick, J. B. et al. S-nitrosylation of mitochondrial caspases. J. Cell Biol. 154, 1111–1116 (2001).
Drury, P. P., Gunn, E. R., Bennet, L. & Gunn, A. J. Mechanisms of hypothermic neuroprotection. Clin. Perinatol. 41, 161–175 (2014).
Thoresen, M. et al. Post-hypoxic hypothermia reduces cerebrocortical release of NO and excitotoxins. NeuroReport 8, 3359–3362 (1997).
McManus, T. et al. Intraischaemic hypothermia reduces free radical production and protects against ischaemic insults in cultured hippocampal slices. J. Neurochem. 91, 327–336 (2004).
Lei, B., Adachi, N. & Arai, T. The effect of hypothermia on H2O2 production during ischemia and reperfusion: a microdialysis study in the gerbil hippocampus. Neurosci. Lett. 222, 91–94 (1997).
Kader, A. et al. Effect of mild hypothermia on nitric oxide synthesis during focal cerebral ischemia. Neurosurgery 35, 272–277 (1994). discussion 277.
Kida, K. et al. Beneficial effects of nitric oxide on outcomes after cardiac arrest and cardiopulmonary resuscitation in hypothermia-treated mice. Anesthesiology 120, 880–889 (2014).
Aaltonen, M. et al. Meconium aspiration induces neuronal injury in piglets. Acta Paediatr. 94, 1468–1475 (2005).
Aaltonen, M. et al. Inhaled nitric oxide treatment inhibits neuronal injury after meconium aspiration in piglets. Early Hum. Dev. 83, 77–85 (2007).
Iadecola, C. Does nitric oxide mediate the increases in cerebral blood flow elicited by hypercapnia? Proc. Natl Acad. Sci. USA 89, 3913–3916 (1992).
Niwa, K., Lindauer, U., Villringer, A. & Dirnagl, U. Blockade of nitric oxide synthesis in rats strongly attenuates the CBF response to extracellular acidosis. J. Cereb. Blood Flow Metab. 13, 535–539 (1993).
Adachi, T., Inanami, O. & Sato, A. Nitric oxide (NO) is involved in increased cerebral cortical blood flow following stimulation of the nucleus basalis of Meynert in anesthetized rats. Neurosci. Lett. 139, 201–204 (1992).
Iadecola, C. & Zhang, F. Nitric oxide-dependent and -independent components of cerebrovasodilation elicited by hypercapnia. Am. J. Physiol. 266, R546–R552 (1994).
Moenkhoff, M. et al. Electroencephalogram changes during inhalation with nitric oxide in the pediatric intensive care patient—a preliminary report. Crit. Care Med. 26, 1887–1892 (1998).
Lopes Cardozo, R. H. et al. Inhalation of nitric oxide: effect on cerebral hemodynamics and activity, and antioxidant status in the newborn lamb. Biol. Neonate 69, 284–292 (1996).
Tsai, G. E. & Gastfriend, D. R. Nitric oxide-induced motor neuron disease in a patient with alcoholism. N. Engl. J. Med. 332, 1036 (1995).
Murohara, T. et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101, 2567–2578 (1998).
Lee, P. C. et al. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am. J. Physiol. 277, H1600–H1608 (1999).
Fukumura, D. et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl Acad. Sci. USA 98, 2604–2609 (2001).
Sessa, W. C. et al. The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J. Biol. Chem. 270, 17641–17644 (1995).
Shesely, E. G. et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA 93, 13176–13181 (1996).
Brock, T. A., Dvorak, H. F. & Senger, D. R. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. Am. J. Pathol. 138, 213–221 (1991).
He, H. et al. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J. Biol. Chem. 274, 25130–25135 (1999).
Papapetropoulos, A., Garcia-Cardena, G., Madri, J. A. & Sessa, W. C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100, 3131–3139 (1997).
Michell, B. J. et al. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 9, 845–848 (1999).
McCabe, T. J., Fulton, D., Roman, L. J. & Sessa, W. C. Enhanced electron flux and reduced calmodulin dissociation may explain “calcium-independent” eNOS activation by phosphorylation. J. Biol. Chem. 275, 6123–6128 (2000).
Kimura, H. & Esumi, H. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim. Pol. 50, 49–59 (2003).
Ku, D. D., Zaleski, J. K., Liu, S. & Brock, T. A. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. 265, H586–H592 (1993).
Chan-Ling, T., Gock, B. & Stone, J. The effect of oxygen on vasoformative cell division. Evidence that ‘physiological hypoxia’ is the stimulus for normal retinal vasculogenesis. Invest. Ophthalmol. Vis. Sci. 36, 1201–1214 (1995).
Hartnett, M. E. & Penn, J. S. Mechanisms and management of retinopathy of prematurity. N. Engl. J. Med. 367, 2515–2526 (2012).
Donohue, P. K. et al. Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics 127, e414–e422 (2011).
van Sorge, A. J. et al. Nationwide inventory of risk factors for retinopathy of prematurity in the Netherlands. J. Pediatr. 164, 494–498 e491 (2014).
Askie, L. M. et al. Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials. Pediatrics 128, 729–739 (2011).
Ahearn, J., Panda, M., Carlisle, H. & Chaudhari, T. Impact of inhaled nitric oxide stewardship programme in a neonatal intensive care unit. J. Paediatr. Child Health 56, 265–271 (2020).
Shiraishi, J. et al. Standardization of nitric oxide inhalation in extremely preterm infants in Japan. Pediatr. Int. 61, 152–157 (2019).
Weinberger, B. et al. Inhaled nitric oxide primes lung macrophages to produce reactive oxygen and nitrogen intermediates. Am. J. Respir. Crit. Care Med. 158, 931–938 (1998).
Kinsella, J. P. et al. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr. Res. 41, 457–463 (1997).
Guidot, D. M., Hybertson, B. M., Kitlowski, R. P. & Repine, J. E. Inhaled NO prevents IL-1-induced neutrophil accumulation and associated acute edema in isolated rat lungs. Am. J. Physiol. 271, L225–L229 (1996).
Sato, Y. et al. Nitric oxide reduces the sequestration of polymorphonuclear leukocytes in lung by changing deformability and CD18 expression. Am. J. Respir. Crit. Care Med. 159, 1469–1476 (1999).
Ekekezie, I. I. et al. Independent and combined effects of prolonged inhaled nitric oxide and oxygen on lung inflammation in newborn piglets. Biol. Neonate 77, 37–44 (2000).
ter Horst, S. A. et al. Inhaled nitric oxide attenuates pulmonary inflammation and fibrin deposition and prolongs survival in neonatal hyperoxic lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L35–L44 (2007).
Haynes, R. L. et al. Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol. 15, 225–233 (2005).
Weinberger, B., Laskin, D. L., Heck, D. E. & Laskin, J. D. The toxicology of inhaled nitric oxide. Toxicol. Sci. 59, 5–16 (2001).
Pham, H. et al. Impact of inhaled nitric oxide on white matter damage in growth-restricted neonatal rats. Pediatr. Res. 77, 563–569 (2015).
Chen, W. et al. Neuroprotective effect of allicin against traumatic brain injury via Akt/endothelial nitric oxide synthase pathway-mediated anti-inflammatory and anti-oxidative activities. Neurochem. Int. 68, 28–37 (2014).
Charriaut-Marlangue, C. et al. Nitric oxide signaling in the brain: a new target for inhaled nitric oxide? Ann. Neurol. 73, 442–448 (2013).
Da, J., Chen, L. & Hedenstierna, G. Nitric oxide up-regulates the glucocorticoid receptor and blunts the inflammatory reaction in porcine endotoxin sepsis. Crit. Care Med. 35, 26–32 (2007).
R.S. holds the “William Buchanan Chair in Pediatrics,” and L.C. is supported by NIH Grant 1R01NS102617-01.
R.S. is on the Scientific Advisory Council of Mallinckrodt Pharmaceuticals and had no role in the development of this review. D.A. and L.C. have no conflicts of interest to disclose.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Angelis, D., Savani, R. & Chalak, L. Nitric oxide and the brain. Part 2: Effects following neonatal brain injury—friend or foe?. Pediatr Res 89, 746–752 (2021). https://doi.org/10.1038/s41390-020-1021-4
Changes in nitric oxide, zinc and metallothionein levels in limbic regions at pre-pubertal and post-pubertal ages presented in an animal model of schizophrenia
Journal of Chemical Neuroanatomy (2021)
American Journal of Perinatology (2020)